What Orbimed Advisors LLC reported holding on Form 13F for the quarter ended Sep 30, 2026.
CIK 1055951 · Filed Nov 16, 2026
Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR
| 24.2M |
| New |
| $482.7M |
| 8.8% |
ELVNEnliven Therapeutics, Inc. | 6.8M | ±0% | $310.6M | 5.6% |
LLYEli Lilly & Co | 257.9K | ±0% | $298.4M | 5.4% |
BRVEBraveheart Bio, Inc. | 12.2M | New | $245.9M | 4.5% |
SVASinovac Biotech Ltd | 2.7M | ±0% | $195.5M | 3.6% |
MBXMBX Biosciences, Inc. | 3.1M | −10.3% | $180.2M | 3.3% |
MRKMerck & Co., Inc. | 946.1K | +42.6% | $137.5M | 2.5% |
GHGuardant Health, Inc. | 584.1K | +0.1% | $104.2M | 1.9% |
AVBPArriVent BioPharma, Inc. | 3M | ±0% | $91.7M | 1.7% |
CRVSCorvus Pharmaceuticals, Inc. | 7.2M | ±0% | $82.5M | 1.5% |
NTRANatera, Inc. | 199.7K | −23.8% | $82.5M | 1.5% |
ARQTArcutis Biotherapeutics, Inc. | 3.1M | +52.9% | $82.5M | 1.5% |
TMOThermo Fisher Scientific Inc. | 120.4K | +32.7% | $81.3M | 1.5% |
UNHUnitedHealth Group Inc | 219K | +35.9% | $80.4M | 1.5% |
ASNDAscendis Pharma A/S | 345.2K | +41.2% | $78.6M | 1.4% |
ETRAElectra Therapeutics, Inc. | 6.9M | New | $77.5M | 1.4% |
ARGXArgenx SE | 75.2K | −19.1% | $72.1M | 1.3% |
EWEdwards Lifesciences Corp | 834.9K | ±0% | $72.1M | 1.3% |
TVTXTravere Therapeutics, Inc. | 1.2M | +374.5% | $70.7M | 1.3% |
TNGXTango Therapeutics, Inc. | 2.8M | New | $69.3M | 1.3% |
ABBVAbbVie Inc. | 259.6K | New | $67.9M | 1.2% |
CAICaris Life Sciences, Inc. | 2.2M | −21.9% | $67.2M | 1.2% |
ODTXOdyssey Therapeutics, Inc. | 3M | ±0% | $66.7M | 1.2% |
COGTCogent Biosciences, Inc. | 2M | +19.2% | $64.2M | 1.2% |
AZNAstraZeneca PLC | 379.3K | −58.6% | $61.8M | 1.1% |
CDNACareDx, Inc. | 934.8K | New | $60.8M | 1.1% |
PRAXPraxis Precision Medicines, Inc. | 200.4K | −12.9% | $58.4M | 1.1% |
ABTAbbott Laboratories | 579K | New | $57.2M | 1% |
PRLDPrelude Therapeutics Inc | 13.7M | ±0% | $53.7M | 1% |
BLSMBlossomHill Therapeutics, Inc. | 2.7M | New | $50.6M | 0.9% |
HUMHumana Inc | 127.8K | −22.1% | $48.8M | 0.9% |
STTKShattuck Labs, Inc. | 6.3M | ±0% | $43M | 0.8% |
GPCRStructure Therapeutics Inc. | 1.3M | −39.8% | $41.6M | 0.8% |
URGNUroGen Pharma Ltd. | 988.5K | +46.2% | $40.2M | 0.7% |
ISRGIntuitive Surgical Inc | 96.8K | −38.7% | $39.4M | 0.7% |
RYTMRhythm Pharmaceuticals, Inc. | 408K | +26.4% | $38.8M | 0.7% |
MLYSMineralys Therapeutics, Inc. | 1.5M | −31.1% | $36.6M | 0.7% |
SPRYARS Pharmaceuticals, Inc. | 8.3M | ±0% | $35.7M | 0.6% |
QTTBQ32 Bio Inc. | 4.1M | ±0% | $34.1M | 0.6% |
KRYSKrystal Biotech, Inc. | 97.7K | +17.4% | $32.5M | 0.6% |
PVLAPalvella Therapeutics, Inc. | 229.9K | −21.4% | $31.7M | 0.6% |
AXSMAxsome Therapeutics, Inc. | 170.9K | +45.3% | $31.5M | 0.6% |
JAZZJazz Pharmaceuticals plc | 131.1K | New | $30.4M | 0.6% |
UPBUpstream Bio, Inc. | 5.7M | ±0% | $30M | 0.5% |
WSTWest Pharmaceutical Services Inc | 80.2K | +13.6% | $29.7M | 0.5% |
LTGOLatigo Biotherapeutics, Inc. | 1.7M | New | $28M | 0.5% |
CELCCelcuity Inc. | 314.5K | New | $25M | 0.5% |
SCTXScribe Therapeutics, Inc. | 1.3M | New | $24.8M | 0.5% |
DXCMDexCom Inc | 278K | New | $24M | 0.4% |
NKTRNektar Therapeutics | 384.5K | −17.4% | $23.3M | 0.4% |
PRELUDE THERAPEUTICS INCNONVOTING | 5.7M | New | $22.2M | 0.4% |
VOGXVogenx, Inc. | 968.6K | New | $22.1M | 0.4% |
| 150K | ±0% | $21.1M | 0.4% |
ORICOric Pharmaceuticals, Inc. | 1.6M | −22.8% | $21M | 0.4% |
AURAAura Biosciences, Inc. | 3.3M | ±0% | $20.9M | 0.4% |
SVRASavara Inc | 4M | ±0% | $20.4M | 0.4% |
APMDApnimed, Inc. | 925K | New | $20.3M | 0.4% |
QUREuniQure N.V. | 811K | −55.1% | $19.6M | 0.4% |
IMTXImmatics N.V. | 2.2M | New | $19.6M | 0.4% |
PYXSPyxis Oncology, Inc. | 8.4M | New | $19.5M | 0.4% |
ACHVAchieve Life Sciences, Inc. | 2.3M | New | $19M | 0.3% |
ABVXAbivax S.A. | 185K | −66.1% | $18.3M | 0.3% |
BIIBBiogen Inc. | 79.4K | +28.9% | $17.9M | 0.3% |
KNSAKiniksa Pharmaceuticals International, plc | 238.9K | −43.2% | $17.8M | 0.3% |
WATWaters Corp | 40.3K | ±0% | $17.7M | 0.3% |
DFTXDefinium Therapeutics, Inc. | 443.9K | +21.5% | $16.9M | 0.3% |
CLDXCelldex Therapeutics, Inc. | 505K | New | $16.4M | 0.3% |
CMPXCompass Therapeutics, Inc. | 15.2M | ±0% | $15.8M | 0.3% |
CVSCVS Health Corp | 182.6K | New | $15.6M | 0.3% |
NPCENeuroPace Inc | 1.1M | −29.9% | $14.5M | 0.3% |
WHWKWhitehawk Therapeutics, Inc. | 3.9M | −2.1% | $14.5M | 0.3% |
RVMDRevolution Medicines, Inc. | 70.5K | ±0% | $14.5M | 0.3% |
TRVITrevi Therapeutics, Inc. | 965.3K | −32.5% | $13.8M | 0.3% |
VRTXVertex Pharmaceuticals Inc | 26.2K | New | $13.7M | 0.2% |
SIONSionna Therapeutics, Inc. | 2.5M | −3.4% | $13M | 0.2% |
ARWRArrowhead Pharmaceuticals, Inc. | 194.3K | New | $12.7M | 0.2% |
BCRXBiocryst Pharmaceuticals Inc | 1.5M | −18.7% | $12.5M | 0.2% |
STROSutro Biopharma, Inc. | 743.9K | ±0% | $12M | 0.2% |
ERASErasca, Inc. | 806K | +62.5% | $11.8M | 0.2% |
SPRBSpruce Biosciences, Inc. | 242.8K | +21.4% | $11.8M | 0.2% |
CRBPCorbus Pharmaceuticals Holdings, Inc. | 1.7M | −4.1% | $11.4M | 0.2% |
LXEOLexeo Therapeutics, Inc. | 3.2M | −18.9% | $10.8M | 0.2% |
| 100K | −50.0% | $9.9M | 0.2% |
TSHATaysha Gene Therapies, Inc. | 2M | ±0% | $9.7M | 0.2% |
JANXJanux Therapeutics, Inc. | 524.7K | ±0% | $9.1M | 0.2% |
KROSKeros Therapeutics, Inc. | 759.2K | ±0% | $8.7M | 0.2% |
RLMDRelmada Therapeutics, Inc. | 1.7M | −54.0% | $6.3M | 0.1% |
| 30K | −40.0% | $6.2M | 0.1% |
ACETAdicet Bio, Inc. | 844.8K | ±0% | $6M | 0.1% |
YARWYarrow Bioscience, Inc. | 266.3K | New | $6M | 0.1% |
TRAVERE THERAPEUTICS INCNOTE 0.500% 5/1 | 5M | ±0% | $5.9M | 0.1% |
XLOXilio Therapeutics, Inc. | 592.3K | ±0% | $5.4M | 0.1% |
BIOABioAge Labs, Inc. | 711.8K | −5.4% | $5M | 0.1% |
REVOLUTION MEDICINES INCNOTE 0.500% 5/0 | 3.5M | ±0% | $4.5M | 0.1% |
IMUXImmunic, Inc. | 475.8K | New | $4.4M | 0.1% |
SYRESpyre Therapeutics, Inc. | 47.3K | −74.6% | $4.2M | 0.1% |
IMAImageneBio, Inc. | 909.3K | ±0% | $4.2M | 0.1% |
DHRDanaher Corp | 18.6K | New | $4.1M | 0.1% |
ALMSAlumis Inc. | 548.2K | ±0% | $4.1M | 0.1% |
DRUGBright Minds Biosciences Inc. | 81K | −12.9% | $4M | 0.1% |
MDGLMadrigal Pharmaceuticals, Inc. | 8K | New | $4M | 0.1% |
AORTArtivion, Inc. | 175K | ±0% | $4M | 0.1% |
TECXTectonic Therapeutic, Inc. | 166.1K | −26.7% | $3.9M | 0.1% |
ALXOALX Oncology Holdings Inc | 2.7M | −4.3% | $3.8M | 0.1% |
| 150K | New | $3.7M | 0.1% |
DNTHDianthus Therapeutics, Inc. | 42.3K | −63.2% | $3.7M | 0.1% |
ZNTLZentalis Pharmaceuticals, Inc. | 1.3M | −5.4% | $3.6M | 0.1% |
BMRNBioMarin Pharmaceutical Inc | 54.3K | New | $3.3M | 0.1% |
PTCTPTC Therapeutics, Inc. | 49.1K | ±0% | $3.2M | 0.1% |
BRKRBruker Corp | 48.4K | New | $3.1M | 0.1% |
TARSTarsus Pharmaceuticals, Inc. | 34.6K | −2.8% | $2.7M | 0.1% |
EYPTEyePoint, Inc. | 739.7K | −30.8% | $2.4M | 0.1% |
BLTEBelite Bio, Inc | 13.3K | ±0% | $2.3M | 0.1% |
NSPRInspireMD, Inc. | 3.1M | ±0% | $2.1M | 0.1% |
| 250K | New | $2.1M | 0.1% |
UNCYUnicycive Therapeutics, Inc. | 387K | New | $1.8M | 0.1% |
EPRXEupraxia Pharmaceuticals Inc. | 194.7K | −27.6% | $1.8M | 0.1% |
OCULOcular Therapeutix, Inc | 220K | ±0% | $1.7M | 0.1% |
EVMNEvommune, Inc. | 161K | ±0% | $1.3M | 0.1% |
| 100K | New | $1.3M | 0.1% |
| 100K | +8.1% | $1.2M | 0.1% |
TRAWTraws Pharma, Inc. | 1.2M | ±0% | $714.5K | 0.1% |
| 1.2M | New | $120.1K | 0.1% |